Machine learning predicts survival and chemotherapy benefit in gastric cancer
A machine learning model developed by researchers in China may soon help surgeons answer one of the most persistent questions in gastric cancer treatment: which patients actually need chemotherapy after surgery, and which can safely skip it.
Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Related signals
- Precision medicine in gastric cancer
- Gastric cancer
- DESTINY‑Gastric05 Phase 3 Trial of ENHERTU Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer
- Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
- Nivolumab/Chemo Yields Long-Term Survival in Advanced Gastric Cancers